https://www.taxtmi.com/article/detailed?id=15158 Pharmaceutical manufacturers must implement segregation, pre-treatment/detoxification (AOPs, adsorption), biological treatment (MBR/SBR/UASB) to reduce BOD/COD, tertiary RO for water recovery, and MEE/crystallization to concentrate RO reject, with evaporator salts and dewatered sludge managed as hazardous waste and online effluent monitoring and ZLD reporting required for regulatory compliance. en-us Wed, 01 Oct 2025 09:08:16 +0530 Wed, 01 Oct 2025 09:08:16 +0530 TaxTMI RSS Generator https://www.taxtmi.com/article/detailed?id=15158 Pharmaceutical manufacturers must implement segregation, pre-treatment/detoxification (AOPs, adsorption), biological treatment (MBR/SBR/UASB) to reduce BOD/COD, tertiary RO for water recovery, and MEE/crystallization to concentrate RO reject, with evaporator salts and dewatered sludge managed as hazardous waste and online effluent monitoring and ZLD reporting required for regulatory compliance. Articles Environmental Law Wed, 01 Oct 2025 09:08:16 +0530 https://www.taxtmi.com/article/detailed?id=15158